Sanofi - Aventis Groupe: Press Release: Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission

Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission First and only next-generation protein-based adjuvanted COVID-19 booster approved

Related Keywords

Paris ,France General ,France ,Eva Schaefer Jansen ,Corentine Driancourt ,Evan Berland ,Felix Lauscher ,Biontech Comirnaty ,Vidprevtyn Beta ,Thomas Triomphe ,Nathalie Pham ,Sandrine Guendoul ,Philip Dormitzer ,Sally Bain ,Priya Nanduri ,Human Services Under Contract ,Us Department Of Health ,Biomedical Advanced Research ,National Institute Of Allergy ,European Commission ,Administration For Strategic Preparedness ,Development Authority ,Nasdaq ,Pfizer ,Nuclear Defense Under Contract ,Global Head Of Research ,Development Vaccines ,Euronext ,European Medicines Agency ,Medicinal Products ,Human Use ,Prevtyn Beta ,Advance Purchase ,Vice President ,Lassistance Publique ,Strategic Preparedness ,Human Services ,Defense Joint Program Executive Office ,Nuclear Defense ,National Institute ,Infectious Diseases ,Private Securities Litigation Reform Act ,Statement Regarding Forward Looking ,Sanofi ,Eventis ,Roupe ,Dress ,Release ,Text ,Generation ,Covid ,Rooster ,Vaccine ,Vidprevtyn ,Meta ,Approved ,European ,Commission ,